UBS Group’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

UBS Group’s Portfolio MSOS Stock Details MSOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-747,600	Closed	-$5.36M	–	10234
2024 Q3	$5.36M	Buy	747,600 +299,800	+67%	+$2.13M	﹤0.01%	3000
2024 Q2	$3.28M	Buy	+447,800	New	+$3.91M	﹤0.01%	3260
2024 Q1	–	Sell	-314,200	Closed	-$2.2M	–	9778
2023 Q4	$2.2M	Buy	+314,200	New	+$2.09M	﹤0.01%	3719
2023 Q1	–	Sell	-382,500	Closed	-$2.67M	–	10072
2022 Q4	$2.67M	Buy	+382,500	New	+$3.93M	﹤0.01%	3095
2022 Q2	–	Sell	-93,600	Closed	-$1.95M	–	10691
2022 Q1	$1.95M	Buy	+93,600	New	+$2.04M	﹤0.01%	3450

Other funds holding MSOS

AdvisorShares Investments Bethesda, Maryland $796M AUM 17.24% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

KAM

Kazazian Asset Management Fort Lauderdale, Florida $115M AUM 9.41% 1-Year Est. Return

IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return

Compass Financial Management Tampa, Florida $926M AUM

Geneos Wealth Management Englewood, Colorado $5.32B AUM 16.49% 1-Year Est. Return

Private Advisor Group Morristown, New Jersey $29.9B AUM 19.22% 1-Year Est. Return

UBS Group's MSOS Position: Q3 2026 in Review

UBS Group increased its AdvisorShares Pure US Cannabis ETF (MSOS) stake by 1.5% in Q3 2026, buying an estimated $5.89K and bringing the position to 87,461 shares worth $395K. The position accounts for ﹤0.01% of the portfolio, ranked #6309.

UBS Group first reported a position in MSOS in Q2 2021 and has held it in 19 quarters since. The position peaked at $2.85M in Q1 2024. 97 funds tracked by Wall St. Rank hold MSOS as of Q3 2026.

UBS Group held 87,461 shares of AdvisorShares Pure US Cannabis ETF worth $395K as of Q3 2026.
UBS Group bought 1,257 AdvisorShares Pure US Cannabis ETF shares in Q3 2026, an estimated $5.89K.
AdvisorShares Pure US Cannabis ETF made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #6309 holding.
UBS Group first reported a position in AdvisorShares Pure US Cannabis ETF in Q2 2021 and has held it in 19 quarters since.
UBS Group's AdvisorShares Pure US Cannabis ETF position peaked at $2.85M in Q1 2024.
97 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.